 |
|
Treatment of Today's Scabies and Pediculosis
Milton Orkin, MD;
Ervin Epstein, Sr, MD;
Howard I. Maibach, MD
JAMA. 1976;236(10):1136-1139.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
|
|
RECENTLY we noted1 the increase of scabies in the United States following an eight-year pandemic in most of the world.2,3 The cyclic nature of scabies epidemics is not understood, but immunologic factors, especially delayed hypersensitivity, probably play a significant role.4 Based on extrapolation from experience in previous cycles in this century, the current epidemic may abate by approximately 1980.
SCABIES
Principles of Management
The diagnosis should be made with certainty, preferably by identifying the mite (principally in direct skin scrapings, at times by cutaneous biopsy) prior to instituting therapy. If the mite cannot be detected, there should be a review of suggestive features, and the more such features, the more positive is the diagnosis.
A decision as to risk-to-benefit ratio must take into account the efficacy of the scabicide. Unfortunately, there has been limited interest in comparative, controlled efficacy trials of scabicides since World War II.
The
. . . [Full Text PDF of this Article]
Author Affiliations
From the departments of dermatology, University of Minnesota Medical School, Minneapolis (Dr Orkin), and University of California Medical School, San Francisco (Drs Epstein and Maibach).
Footnotes
Reprint requests to Department of Dermatology, Box 98 Mayo, University of Minnesota Medical School, Minneapolis, MN 55455 (Dr Orkin).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
